Aida Al-Akhdar

ArentFox Schiff

Contact
View Bio
RSS

Latest Posts › Advisory Opinions

Share:

Vertex’s Attempt to Redefine AKS Falls Short: Key Insights for Pharma Manufacturers

In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of the Inspector General (OIG), manufacturers have contested the OIG’s...more

4/16/2025  /  Advisory Opinions , Anti-Kickback Statute , Department of Health and Human Services (HHS) , Healthcare Fraud , Manufacturers , OIG , Pharmaceutical Industry , Prescription Drugs , Regulatory Requirements , Statutory Interpretation
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide